Report Detail

Pharma & Healthcare Global Latanoprost Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3050490
  • |
  • 04 March, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.

Scope of the Report:
Latanoprost is widely used in the treatment of Open-angle Glaucoma and Closed-angle Glaucoma. The most proportion of Latanoprost is Open-angle Glaucoma, and the sales market share in 2016 is about 82%.
North America is the largest supplier and Europe is in the second place of production market with market share of 36.5% and 28.9%. On the other hand, North America and Europe are also the top 2 consumption market with market share of 36.3% and 20.5%.
The worldwide market for Latanoprost is expected to grow at a CAGR of roughly 2.3% over the next five years, will reach 1440 million US$ in 2024, from 1260 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Latanoprost in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Brand Drug
Generic Drug

Market Segment by Applications, can be divided into
Open-angle Glaucoma
Close-angle Glaucoma

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Latanoprost product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Latanoprost, with price, sales, revenue and global market share of Latanoprost in 2017 and 2018.
Chapter 3, the Latanoprost competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Latanoprost breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Latanoprost market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Latanoprost sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Latanoprost Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Brand Drug
      • 1.2.2 Generic Drug
    • 1.3 Market Analysis by Applications
      • 1.3.1 Open-angle Glaucoma
      • 1.3.2 Close-angle Glaucoma
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Pfizer
      • 2.1.1 Business Overview
      • 2.1.2 Latanoprost Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Pfizer Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Mylan
      • 2.2.1 Business Overview
      • 2.2.2 Latanoprost Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Mylan Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Novartis
      • 2.3.1 Business Overview
      • 2.3.2 Latanoprost Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Novartis Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Apotex
      • 2.4.1 Business Overview
      • 2.4.2 Latanoprost Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Apotex Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Teva
      • 2.5.1 Business Overview
      • 2.5.2 Latanoprost Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Teva Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Taj Pharma
      • 2.6.1 Business Overview
      • 2.6.2 Latanoprost Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Taj Pharma Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 CR Zizhu
      • 2.7.1 Business Overview
      • 2.7.2 Latanoprost Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 CR Zizhu Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Latanoprost Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Latanoprost Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Latanoprost Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Latanoprost Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Latanoprost Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Latanoprost Market Analysis by Regions

    • 4.1 Global Latanoprost Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Latanoprost Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Latanoprost Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Latanoprost Sales and Growth Rate (2014-2019)
    • 4.3 Europe Latanoprost Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Latanoprost Sales and Growth Rate (2014-2019)
    • 4.5 South America Latanoprost Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Latanoprost Sales and Growth Rate (2014-2019)

    5 North America Latanoprost by Country

    • 5.1 North America Latanoprost Sales, Revenue and Market Share by Country
      • 5.1.1 North America Latanoprost Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Latanoprost Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Latanoprost Sales and Growth Rate (2014-2019)
    • 5.3 Canada Latanoprost Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Latanoprost Sales and Growth Rate (2014-2019)

    6 Europe Latanoprost by Country

    • 6.1 Europe Latanoprost Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Latanoprost Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Latanoprost Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Latanoprost Sales and Growth Rate (2014-2019)
    • 6.3 UK Latanoprost Sales and Growth Rate (2014-2019)
    • 6.4 France Latanoprost Sales and Growth Rate (2014-2019)
    • 6.5 Russia Latanoprost Sales and Growth Rate (2014-2019)
    • 6.6 Italy Latanoprost Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Latanoprost by Country

    • 7.1 Asia-Pacific Latanoprost Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Latanoprost Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Latanoprost Revenue and Market Share by Country (2014-2019)
    • 7.2 China Latanoprost Sales and Growth Rate (2014-2019)
    • 7.3 Japan Latanoprost Sales and Growth Rate (2014-2019)
    • 7.4 Korea Latanoprost Sales and Growth Rate (2014-2019)
    • 7.5 India Latanoprost Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Latanoprost Sales and Growth Rate (2014-2019)

    8 South America Latanoprost by Country

    • 8.1 South America Latanoprost Sales, Revenue and Market Share by Country
      • 8.1.1 South America Latanoprost Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Latanoprost Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Latanoprost Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Latanoprost Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Latanoprost Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Latanoprost by Countries

    • 9.1 Middle East and Africa Latanoprost Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Latanoprost Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Latanoprost Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Latanoprost Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Latanoprost Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Latanoprost Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Latanoprost Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Latanoprost Sales and Growth Rate (2014-2019)

    10 Global Latanoprost Market Segment by Type

    • 10.1 Global Latanoprost Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Latanoprost Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Latanoprost Revenue and Market Share by Type (2014-2019)
    • 10.2 Brand Drug Sales Growth and Price
      • 10.2.1 Global Brand Drug Sales Growth (2014-2019)
      • 10.2.2 Global Brand Drug Price (2014-2019)
    • 10.3 Generic Drug Sales Growth and Price
      • 10.3.1 Global Generic Drug Sales Growth (2014-2019)
      • 10.3.2 Global Generic Drug Price (2014-2019)

    11 Global Latanoprost Market Segment by Application

    • 11.1 Global Latanoprost Sales Market Share by Application (2014-2019)
    • 11.2 Open-angle Glaucoma Sales Growth (2014-2019)
    • 11.3 Close-angle Glaucoma Sales Growth (2014-2019)

    12 Latanoprost Market Forecast (2019-2024)

    • 12.1 Global Latanoprost Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Latanoprost Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Latanoprost Market Forecast (2019-2024)
      • 12.2.2 Europe Latanoprost Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Latanoprost Market Forecast (2019-2024)
      • 12.2.4 South America Latanoprost Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Latanoprost Market Forecast (2019-2024)
    • 12.3 Latanoprost Market Forecast by Type (2019-2024)
      • 12.3.1 Global Latanoprost Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Latanoprost Market Share Forecast by Type (2019-2024)
    • 12.4 Latanoprost Market Forecast by Application (2019-2024)
      • 12.4.1 Global Latanoprost Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Latanoprost Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Latanoprost . Industry analysis & Market Report on Latanoprost is a syndicated market report, published as Global Latanoprost Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Latanoprost market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,686.56
      4,029.84
      5,373.12
      3,198.12
      4,797.18
      6,396.24
      529,203.60
      793,805.40
      1,058,407.20
      292,876.80
      439,315.20
      585,753.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report